SCHEMBL5590144

SCHEMBL5590144

Cc1c(C)c(O)c(O)c(C(=O)O)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 7/20 0.57
LDHB P07195 7/20 0.57
DPP4 P27487 1/20 0.39
CYP3A4 P08684 2/20 0.37
ACHE P22303 1/20 0.37
GLRA3 O75311 1/20 0.37
GLRB P48167 1/20 0.37
MAPT P10636 1/20 0.35
ALB P02768 3/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
GRM1 Q13255 1/20 0.33
NOTUM Q6P988 1/20 0.33
APP P05067 1/20 0.33
BACE1 P56817 1/20 0.33
PSMG3 Q9BT73 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8830267 0.92 LDHA (0.48) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL10404342 0.92 LDHA (0.52) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL19193900 0.86 LDHA (0.54) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL29434000 0.84 LDHA (0.42) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL274096 0.84 LDHA (0.42) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL4124451 0.83 LDHA (0.50) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL28389101 0.83 LDHA (0.45) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL19193997 0.83 LDHA (0.56) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL18677490 0.81 LDHA (0.48) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL7577609 0.80 LDHA (0.46) LDHALDHBDPP4CYP3A4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885DPP4 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.